A. Menarini Industrie Farmaceutiche Riunite S.r.l.
- Address
- Via Dei Sette Santi 3
Sponsor Overview
Specializations
Cardiovascular Disease Management
The sponsor maintains a focused research portfolio in cardiovascular therapeutics, with particular emphasis on conditions affecting cardiac function and vascular health. Their clinical investigations target patients experiencing acute coronary syndromes and related cardiovascular events requiring specialized medical intervention.
- Acute Myocardial Infarction Treatment
- Coronary Artery Disease Interventions
- Cardiac Event Prevention Strategies
Research activities concentrate on developing therapeutic approaches for patients undergoing percutaneous coronary intervention and those at risk of major adverse cardiovascular events, addressing critical needs in emergency cardiac care and secondary prevention.
Antiplatelet and Antithrombotic Therapy
A significant area of therapeutic interest involves the investigation of antiplatelet agents and their role in preventing thrombotic complications. The research encompasses novel approaches to managing platelet aggregation in high-risk cardiovascular populations.
- Dual Antiplatelet Therapy Optimization
- Thrombosis Prevention in Acute Coronary Settings
- Platelet Function Modulation
Clinical programmes explore the balance between preventing ischemic events and managing bleeding risk in patients with acute coronary syndrome, particularly those requiring interventional procedures.
Interventional Cardiology Support
The sponsor demonstrates commitment to advancing care in interventional cardiology, supporting research that enhances outcomes for patients undergoing invasive cardiac procedures. Their studies focus on pharmacological support during and after coronary stenting and other revascularization techniques.
- Post-Procedural Complication Prevention
- Stent Thrombosis Risk Reduction
- Periprocedural Medication Strategies
Research initiatives address the specific needs of patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndrome, aiming to improve both immediate procedural success and long-term cardiovascular outcomes.
Sponsored Trials
Data & Insights
This sponsor works with 3 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 10 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
Partnered Research Centres
10 centres- Address
- Jana Sapiehy 2 lok. 4A, 20-095 Lublin
- Address
- Ul. Zgierska 249, 91-495 Lodz
- Address
- Via Sergio Pansini 5, 80131 Naples
- Address
- C/ Oquendo, 23, 28006 Madrid
- Address
- Ul. Prezydenta Gabriela Narutowicza 24, 88-100 Inowrocław
- Address
- Calle Sant Quinti 77-79, 08041 Barcelona
Want to get in touch with this sponsor?
Send a question and we'll pass it on to A. Menarini Industrie Farmaceutiche Riunite S.r.l..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.



